Male Infertility Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

Description

The Global Male Infertility Market is poised to exhibit 4.7% CAGR from 2024 to 2032, driven by increasing awareness and access to advanced treatment options. Infertility is a growing concern worldwide, affecting an estimated 15% of couples globally. According to the World Health Organization (WHO), male infertility contributes to nearly half of these cases, leading to a surge in demand for effective treatment solutions.

The rising awareness of male infertility issues, coupled with advancements in diagnostic techniques and treatment methods, is expected to propel market expansion. Additionally, societal shifts towards later parenting and the growing acceptance of fertility treatments are further bolstering the demand for male infertility solutions.

The overall Male Infertility Industry is classified based on the test, distribution channel, and region.

The treatment segment will experience significant growth over 2024-2032, driven by the availability of various therapeutic options, including medications, surgical interventions, and assisted reproductive technologies (ART). Among these, ART procedures such as intracytoplasmic sperm injection (ICSI) and in vitro fertilization (IVF) are witnessing increasing adoption due to their high success rates. The development of innovative treatments, such as hormonal therapies and gene editing techniques, is also contributing to the growth of this segment. As more men seek solutions to overcome infertility challenges, the treatment segment is expected to capture a substantial share of the market.

Online pharmacies are set to gain a notable share in the Male Infertility Market by 2032, driven by the increasing preference for convenient and discreet purchasing options. The proliferation of e-commerce platforms and the growing trend of digital health consultations are making it easier for patients to access fertility treatments and medications from the comfort of their homes. Online pharmacies offer a wide range of fertility products, often at competitive prices, along with the added benefit of home delivery services. This shift towards online purchasing is particularly significant in regions with limited access to specialized fertility clinics, providing patients with a reliable and accessible option for managing their infertility treatment.

Europe will drive commendable gains in the Male Infertility Market throughout 2024-2032, owing to its advanced healthcare infrastructure, high awareness levels, and supportive government initiatives. The region's strong focus on reproductive health, coupled with significant investment in research and development, is fostering innovation in infertility treatments. Additionally, the presence of leading pharmaceutical companies and fertility clinics in Europe is contributing to the widespread availability of cutting-edge treatments. With a growing number of men seeking medical assistance for infertility issues, the European market is set to experience substantial growth, supported by favorable regulatory environments and increasing acceptance of fertility treatments across the region.

Product Code: 10497

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Advancements in diagnostic technologies
  - 3.2.1.2 Growth in assisted reproductive technologies
  - 3.2.1.3 Increasing research and development in fertility treatments
  - 3.2.1.4 Rising awareness and education
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 High cost of treatment
  - 3.2.2.2 Side effects and complications
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
- 3.5.1 Core technologies
- 3.5.2 Adjacent technologies
3.6 Pricing analysis, 2023
3.7 Future market trends
3.8 Porter's analysis
3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Test
- 5.2.1 DNA fragmentation technique
- 5.2.2 Oxidative stress analysis
- 5.2.3 Microscopic examination
- 5.2.4 Sperm agglutination
- 5.2.5 Computer assisted semen analysis
- 5.2.6 Sperm penetration assay
- 5.2.7 Other tests
5.3 Treatment
- 5.3.1 Medication
- 5.3.2 ART and varicocele surgery reagents and kits

Chapter 6 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Hospitals pharmacies
6.3 Retail pharmacies and drug stores
6.4 Online pharmacies

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Netherlands
- 7.3.7 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.4.6 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.5.4 Rest of Latin America
7.6 Middle East and Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 UAE
- 7.6.4 Rest of Middle East and Africa

Chapter 8 Company Profiles

8.1 Andrology Solutions
8.2 ASKA Pharmaceutical Co., Ltd.
8.3 AdvaCare Pharma
8.4 Bayer AG
8.5 CinnaGen Co.
8.6 CaerusBiotech
8.7 Endo International plc
8.8 HalotechDNA
8.9 Intas Pharmaceuticals Ltd.
8.10 Merck KGaA
8.11 Sanofi
8.12 SCSA Diagnostics, Inc
8.13 The Cooper Companies, Inc.
8.14 Vitrolife Group
8.15 Zydus Lifesciences Limited